The price tag of a potential cure for chronic hepatitis B infection: A cost threshold analysis for USA, China and Australia
The price tag of a potential cure for chronic hepatitis B infection: A cost threshold analysis for USA, China and Australia
M. Toy,D. Hutton,5 Authors,B. Cowie
2021 · DOI: 10.1111/liv.15027
Liver international (Print) · 11 Citations
TLDR
This work aims to capture the economic impact of a potential cure for chronic hepatitis B infection in three countries with different health systems and epidemics to estimate the threshold drug prices below which a CHB cure would be cost‐saving and/or highly cost‐effective.
Abstract
We aim to capture the economic impact of a potential cure for chronic hepatitis B infection (CHB) in three countries (USA, China and Australia) with different health systems and epidemics to estimate the threshold drug prices below which a CHB cure would be cost‐saving and/or highly cost‐effective.